NGNE - Neurogene Inc.

Insider Sale by McMinn Rachel (CEO)

1 Month

After Trade

Before Trade

Loading data...

Trade Summary

1 week ago, McMinn Rachel, serving as CEO at Neurogene Inc. (NGNE), sold 3,352 shares at $22.07 per share, for a total transaction value of $73,995.00. Following this transaction, McMinn Rachel now holds 1,344,307 shares of NGNE.

The trade was executed on Thursday, March 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 30, 2026, 4 days after the trade was made.

Neurogene Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

McMinn Rachel

CEO

View full insider profile →

Trade Price

$22.07

Quantity

3,352

Total Value

$73,995.00

Shares Owned

1,344,307

Trade Date

Thursday, March 26, 2026

10 days ago

SEC Filing Date

Monday, March 30, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Neurogene Inc.

Company Overview

No company information available

View news mentioning NGNE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5228356

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free Account Learn More

✓ Free forever plan available • ✓ No credit card required • ✓ Cancel anytime